Lupin Presents Phase 1 Clinical Data for Investigational Cancer Therapy LNP8701
MM Desk
29 May, 2026
Lupin Limited has announced that results from its ongoing Phase 1a clinical study evaluating LNP8701,
Lupin Limited has announced that results from its ongoing Phase 1a clinical study evaluating LNP8701,